Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
17.98
+0.25 (1.41%)
Dec 12, 2025, 4:00 PM EST - Market closed
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.18 billion as of December 12, 2025. Its market cap has increased by 129.24% in one year.
Market Cap
1.18B
Enterprise Value
1.14B
1-Year Change
129.24%
Ranking
Category
Stock Price
$17.98
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $1.18B, an increase of 814.40%. That is a compound annual growth rate of 8.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 1.18B | 81.37% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | 992.79M | -10.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 886.79B |
| Johnson & Johnson | 491.57B |
| AbbVie | 394.22B |
| UnitedHealth Group | 294.52B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 241.75B |
| Novo Nordisk | 214.17B |